2024-11-19 09:33:38
Asieris Pharmaceuticals (688176.SH) Issued 2022 Semi-Annual Report: Accelerated Global Clinical Development and Progressive Implementation of Its Integrated Diagnosis-Treatment Commercialization Strategy
Corporate/ 2023-07-24
Asieris Pharmaceuticals (688176.SH) Issu...

SHANGHAI,Aug. 25,2022-- Asieris Pharmaceuticals,a global biopharma company specializing in discovering,developing and commercializing innova...

111, Inc. Announces Second Quarter 2022 Unaudited Financial Results
Corporate/ 2023-07-24
111, Inc. Announces Second Quarter 2022 ...

SHANGHAI,Aug. 25,2022-- 111,Inc. ("111" or the "Company") (NASDAQ: YI),a leading tech-enabled healthcare platform compan...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release